Vivo Bio Tech Ltd — Board Meeting, 13-07-2026: Board Meeting
13-07-2026 | 07:41 pm
13-07-2026 | 07:41 pm
Vivo Bio Tech's board approved Q1 financial results. Consolidated revenue from operations stood at ₹14.28 Cr, with Net Profit After Tax at ₹0.19 Cr for the quarter ended June 30, 2026. #VivoBioTech #Q1Results #Earnings
No comments yet. Be the first to comment!
